Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed

Published:2024-05-18 Issue:4 Volume:136 Page:396-405
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Chalet François-Xavier¹,Luyet Pierre-Philippe¹,Rabasa Cristina¹,Vaillant Cédric¹^ORCID,Saskin Paul²,Ahuja Ajay²,Citrome Leslie³^ORCID

Affiliation:

1. Global Clinical Development & Medical Affairs, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland

2. Medical Affairs US, Idorsia Pharmaceuticals US Inc, Radnor, PA, USA

3. Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA

Funder

Idorsia Pharmaceuticals

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2024.2359891

Reference47 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Epidemiology of insomnia: a longitudinal study in a UK population;Morphy H;Sleep,2007

3. Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults

4. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline

5. Cognitive behavioural treatment for insomnia in primary care: a systematic review of sleep outcomes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP